Fiasp Cartridge 3ml is a fast-acting insulin, containing Insulin Aspart 100IU/ml, used for effective blood sugar control in individuals with type 1 and type 2 diabetes mellitus. This medicine helps to lower blood sugar levels quickly after meals, significantly reducing the risk of developing serious diabetes-related complications.

Fiasp Cartridge 3ml is typically prescribed in conjunction with a long-acting insulin or other diabetes medications as part of a comprehensive treatment plan for diabetes. Your doctor or nurse will provide guidance on the correct method for injecting it under the skin. It should be administered at the beginning of a meal or within 20 minutes after starting a meal. Regular monitoring of your blood sugar levels is crucial; keep a detailed record of your results to share with your doctor. This information is vital for determining the appropriate dosage for you.

Do not use Fiasp Cartridge 3ml if you are experiencing low blood sugar levels (hypoglycemia). Inform your doctor about any pre-existing kidney, liver, or heart conditions before commencing treatment. Pregnant or breastfeeding individuals should also consult their doctor, as dosage adjustments may be necessary. Do not discontinue use unless specifically instructed by your doctor. This medication is an integral part of a diabetes management program that includes a healthy diet, consistent exercise, and weight management, as recommended by your healthcare provider.

Common side effects associated with Fiasp Cartridge 3ml include low blood sugar levels (hypoglycemia), headache, nasopharyngitis, and upper respiratory tract infection. To help prevent hypoglycemia, it is important to always inject the correct dose, consume regular meals, and monitor your blood sugar levels frequently. Excessive alcohol consumption can also lead to a drop in blood sugar. Other potential side effects include injection site reactions such as redness, swelling, or the formation of hard lumps (lipodystrophy). Some individuals may experience weight gain while on insulin therapy.